Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. SanBio Company Limited
  6. News
  7. All News
    4592   JP3336750009

SANBIO COMPANY LIMITED

(4592)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about SANBIO COMPANY LIMITED
10/18SANBIO : Notice on Appointment of New Corporate Officer
PU
10/18Sanbio Company Limited Appoints Naoki Tsukahara as New Corporate Officer and Business H..
CI
10/14SANBIO : Announcement on Granting Stock Options (Share Acquisition Rights)
PU
09/22SanBio Records Non-Operating Income, Extraordinary Loss in H1
MT
09/21SANBIO : Notice on Recording of Non-Operating Income and Extraordinary Loss
PU
09/16SANBIO : Presentation for Financial Results for the 2nd Quarter of the Fiscal Year Ending ..
PU
09/14SANBIO : Consolidated Financial Results for the Six Months Ended July 31, 2021
PU
09/14SanBio Company Limited Announces Consolidated Earnings Results for the Six Months Ended..
CI
09/14SanBio Company Limited Provides Consolidated Earnings Guidance for the Fiscal Year Endi..
CI
09/14SANBIO : Notice Concerning Difference Between Consolidated Financial Forecasts and Actual ..
PU
09/14SanBio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fi..
CI
08/31SANBIO : Notice on Conclusion of Committed Credit Line Agreement with MUFG Bank, Ltd
PU
07/29SANBIO : Determination of Terms and Conditions of Stock Options
PU
07/14SANBIO : Announcement on Granting Stock Options (Share Acquisition Rights)
PU
07/01SANBIO : Notice Concerning Changes to Our Lineup of Corporate Officers
PU
07/01SanBio Company Limited Announces Executive Changes
CI
06/23SANBIO : Announcement on Acquisition and Cancellation of Stock Options (Share Acquisition ..
PU
06/15SanBio Trims Attributable Loss in Q1 Despite Lack of Revenue
MT
06/14SanBio Company Limited Announces Consolidated Earnings Results for the First Quarter En..
CI
06/14SanBio Company Limited Provides Consolidated Earnings Guidance for the First Half and F..
CI
05/14SANBIO : Determination of Terms and Conditions of Stock Options
PU
04/28SANBIO : Announcement on Granting Stock Options (Share Acquisition Rights)
PU
04/14SANBIO : Notice Regarding Change of Representative Director
PU
04/14Sanbio Company Limited Appoints Akihiro Tsujimura as Representative Director
CI
03/18SANBIO : Presentation for Financial Results for the Fiscal Year Ending Jan.31, 2021
PU
03/18SANBIO : Posts Narrower Attributable Net Loss in FY20; Shares Climb 6%
MT
03/17SANBIO : Announcement on Reduction in Amounts of Stated Capital and Capital Reserves and A..
PU
03/17SANBIO : Consolidated Financial Results for the Fiscal Year Ended January 31, 2021
PU
03/17SanBio Company Limited Announces Consolidated Earnings Results for the Fiscal Year Ende..
CI
03/17SanBio Company Limited Provides Earnings Guidance for the First Half and Full Year of t..
CI
02/28SANBIO : Presentation of STEMTRA Phase 2 Trial Results at the 44th Annual Meeting of the J..
PU
02/28Sanbio Company Limited Presents STEMTRA Phase 2 Trial Results At the 44Th Annual Meetin..
CI
02/26SANBIO : Notice Concerning Extraordinary Gains (Gain on Sales of Investment Securities) an..
PU
02/25SANBIO : Revision of Consolidated Earnings Forecast for the Fiscal Year Ended January 2021
PU
02/25SANBIO : Announcement on Granting Stock Options (Share Acquisition Rights)
PU
02/25SanBio Company Limited Revises Earnings Guidance for the Full Year Ended January 31, 20..
CI
01/05SANBIO : American Neurology Journal Publishes Sanbio's STEMTRA Phase 2 Interim Analysis fo..
MT
01/04SANBIO : Announces Publication of STEMTRA Phase 2 Interim Analysis for SB623 in Neurology
BU
01/04SanBio Company Limited Announces Publication of STEMTRA Phase 2 Interim Analysis for SB..
CI
2020SANBIO : Signs Two New Credit Facility Agreements
MT
2020SANBIO : to Seek Regulatory OK in Japan for Regenerative Cell Medicine SB623
MT
2020SanBio Company Limited Announces Consolidated Earnings Results for the Nine Months Ende..
CI
2020SanBio Company Limited Provides Consolidated Earning Guidance for the Fiscal Full Year ..
CI
2020SANBIO : to Transfer CareNet Shares to Tokio Marine & Nichido Fire Insurance
MT
2020SanBio Company Limited Appoints Hiroyasu Narita as Head of Clinical Development, Effect..
CI
2020SANBIO : Consolidated Financial Resultsfor the SixMonthsEnded July 31, 2020
PU
2020SANBIO : Presentation for Financial Results for the 2nd Quarter of the Fiscal Year Ending ..
PU
2020SanBio Company Limited Announces Consolidated Earnings Results for the First Half Ended..
CI
2020SANBIO : Notice regarding change in director and corporate officer
PU
2020SANBIO : Additional analytical results of the US-based Phase 2b clinical trial of SB623 fo..
PU
2020SANBIO : Notice regarding the recording of non-operating expenses (foreign exchange losses..
PU
2020SANBIO : Additional Analytical Results of the US-Based Phase 2b Clinical Trial of Regenera..
BU
2020SanBio Company Limited Announces Additional Analytical Results of the US-Based Phase 2b..
CI
2020SanBio Company Limited Appoints Akihiro Tsujimura to the Position of Executive Vice Pre..
CI
2020SanBio Company Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ende..
CI
2020SANBIO : Determination of Terms and Conditions of Stock Options (Share Acquisition Rights)
PU
2020SANBIO : Announcement on Granting Stock Options (Share Acquisition Rights)
PU
2020Sanbio Co., Ltd. Appoints Christopher Horan as Corporate Officer
CI
2020Sanbio Company Limited Announces Consolidated Earnings Results for the First Quarter En..
CI
2020Sanbio Company Limited Provides Earnings Guidance for the First Half and Full Year of t..
CI
2020SanBio Company Limited Releases Analytical Results of Phase 2B Study in the U.S. Evalua..
CI
2020SanBio Co., Ltd. Enters into Business Alliance with Ocumension (Hong Kong) Limited
CI
2020SANBIO : Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research,..
BU
2020Sanbio Company Limited Announces Consolidated Earnings Results for Fiscal Year Ended Ja..
CI
2020SanBio Co., Ltd. and Nippon Medical School Have Enter Joint Research Agreement to Inves..
CI
2020Sanbio Co., Ltd. and Juntendo University Reach Agreement on Joint Research into the Pro..
CI
2019Sanbio Company Limited Announces Consolidated Earnings Results for the Nine Months Ende..
CI
2019The SanBio Group Reaches an Agreement with National University Corporation Asahikawa Me..
CI
2019SANBIO : Granted Regenerative Medicine Advanced Therapy Designation from the U.S. FDA for ..
BU
2019U.S. FDA Grants SanBio for Regenerative Medicine Advanced Therapy Designation from the ..
CI
2019Sanbio Company Limited Announces Consolidated Earnings Results for the Six Months Ended..
CI
2019The SanBio Group Announces the Results of the Phase 2 STEMTRA trial of SB623
CI
2019SanBio Company Limited Announces Consolidated Earnings Results for the First Quarter En..
CI
2019SANBIO : Bijan Nejadnik, M.D., Appointed as Chief Medical Officer of SanBio
BU
2019SANBIO : SB623, an Investigational Product, Granted Advanced Therapy Medicinal Product Cla..
BU
1  2Next
Upcoming event on SANBIO COMPANY LIMITED
12/15/21